ADM Korea Signs Clinical Research Outsourcing Contract Worth 2.3 Billion KRW with Boryung Pharmaceutical
[Asia Economy Reporter Kim Heung-soon] ADM Korea announced on the 1st that it has signed a clinical research outsourcing contract worth 2.365 billion KRW with Boryung Pharmaceutical. This amount corresponds to 18% of recent sales, and the contract period is until October 31, 2023.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Meta Begins 10% Workforce Reduction...Zuckerberg: "No Additional Company-Wide Layoffs This Year"
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
